AI assistant
Take Solutions Ltd — M&A Activity 2019
Mar 7, 2019
60381_rns_2019-03-07_4e5688a9-6264-4366-b52d-6073395984a9.pdf
M&A Activity
Open in viewerOpens in your device viewer

TECHNOLOGY ANALYTICS KNOWLEDGE ENTERPRISE
March 07, 2019
TAKE/BSE/2018-19
Dept. of Corporate Services-Listing Bombay Stock Exchange Limited,
P. J. Towers, Dalal Street,
Mumbai - 400001 Scrip Code: 532890
The Manager
TAKE/NSE/2018-19
The Manager-Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra - Kurla Complex, Bandra (East), Mumbai - 400051 Symbol: TAKE
Sir/ Madam,
Sub: Intimation regarding Merger of Subsidiaries. Ref: Company Intimation to the Stock Exchange on the above subject on March 01, 2019
This Letter is with reference to the above intimation sent by the Company on March 01, 2019 where the Company has informed the exchanges about the details of mergers of its Stepdown subsidiaries in the United States of America.
Due to typo errors, the figures in mn. were inadvertently mentioned at s.no l(a) of Annexure II and Annexure Ill of the said intimation. We have updated these annexures and enclosing herewith the same or your reference and necessary action.
We request you to take note of the aforesaid and acknowledge receipt.
Yours sincerely, For TAKE Solutions Limited
Avaneesh Singh Company Secretary
Encl: As Above

T/\KE SOLUTIONS LIMITED
R0gistc1cd h Co1pointc Office: No: 27, Tilnk Bund Road, Nungilmbakkam, Chennai 600 034 C IN- LC,Hl90TNlilllllPLCCM6llH Tel: ,91 44 6611 0700/01

Annexure-1
Transaction - 1 (a)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: Astus TechnologiesInc, USA merging into TAKE InnovationsInc, USA |
| Turnover as on March 31, 2018 | USD 45.54 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amountor otherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |


Annexure - II
Transaction - 1 (b)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: TAKE DataworksInc, USA merging into TAKE InnovationsInc, USA |
| Turnover as on March 31, 2018 | USO 39.14 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation / merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |

Annexure - Ill
Transaction -1 (c)
| S.No | Particulars | Details of entities forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Name of the entity: TAKE Synergies Inc,USA merging into TAKE Innovations Inc,USA |
| Turnover as on March 31, 2018 | USD 40.77 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation/ merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative andcompliance costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as the Wholly Owned Subsidiarycompany has been merged with itsParent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |


Annexure - IV
Transaction 2
| S.No | Particulars | Details of entity forming part ofmerger |
|---|---|---|
| a) | Details in brief such as size, turnover etc | Nameoftheentity:NavitasLifeSciences Inc merging into Navitas Inc,USA |
| Turnover as on March 31, 2018 | USD 4.21 mn | |
| b) | Whether the merger would fall withinrelated party transaction(s) and whetherthe promoter/ promoter group/ groupcompanies have any interest in the entitybeing acquired? | Not a Related Party Transaction |
| c) | Area of Business of the entities | Life Sciences |
| d) | Rationale for amalgamation / merger | The merger enables a lighter and morerationalized organization structure andresults in fewer administrative costs. |
| e) | In case of Cash consideration -amount orotherwise share exchange ration | None, as both the merged entities aresubsidiary of same parent Company |
| f) | Brief details of change in shareholdingpattern (if any) of Listed Entity | None |